CNS Pharmaceuticals CNSP Q3 2025 earnings
Reported November 14, 2025 · Before market open
EPS estimate-$6.63
Next report
Aug 17, 2026 (in a month)EPS estimate-$0.24
Versus estimates
Diluted EPS
Ask the moment CNS Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did CNS Pharmaceuticals report Q3 2025 earnings?
- CNS Pharmaceuticals (CNSP) reported Q3 2025 earnings on November 14, 2025 before market open.
- What were CNS Pharmaceuticals's Q3 2025 revenue and EPS?
- CNS Pharmaceuticals reported diluted EPS of $-5.76 for Q3 2025.
- Did CNS Pharmaceuticals beat estimates in Q3 2025?
- EPS beat the consensus estimate of $-6.63 by $0.87.
- How did CNS Pharmaceuticals's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS grew 96.2% from $-150.06.
- Where can I find CNS Pharmaceuticals's Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001683168-25-008466) directly on SEC EDGAR. The filing index links above go to sec.gov.